Alzheimer’s disease is a progressive brain disorder that gradually destroys memory and other important mental functions. More than 90% of AD cases are the late-onset form, with symptoms not appearing until after 65 years of age. Two abnormal structures, plaques and tangles, are detected in affected brains. These are the prime suspects for increasing cell death and tissue loss.

Mesenchymal stem cells are actively being explored as a potential therapeutic option for immune-mediated diseases like Alzheimer’s.